Spider venom could soon be used to relieve chronic pain conditions.
Institute for Molecular Bioscience (IMB) researchers have partnered with Johnson & Johnson to develop components of spider venom that may be effective as a treatment for pain.
Sign up for SmartCompany newsletter.
Free to your inbox every weekday
Funding will support a 12-month project to characterise novel spider venom peptides that were discovered in a proprietary IMB testing procedure to inhibit a human ion channel (ion channels regulate ion flows across cell membranes), critical for sensing pain.
The long-term goal is to develop these peptides for the therapeutic treatment of chronic pain.
UniQuest managing director David Henderson says the partnership will accelerate the process of seeking a solution to chronic pain, a health problem estimated to affect 1.5 billion people.
“Discoveries like this pass through many developmental stages before they become market-ready therapeutic products,” Henderson says.
The use of spider venom as a potential treatment for pain could represent a major opportunity for the right entrepreneur, so why not do some research of your own?